High dose atorvastatin effects on cardiac biomarkers (24 hours after CABG)
Not Applicable
- Conditions
- Coronary artery disease.Atherosclerotic heart disease
- Registration Number
- IRCT2016112231024N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 118
Inclusion Criteria
Inclusion criterion: admission for CABG in Tehran Heart Center.
Exclusion criteria: other heart surgeries; COPD; emergent surgeries; liver insufficiency; renal dysfunction ( Cr > 1.5); MI (myocardial infarction) since recent 6 weeks; age > 75 years old.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CKMB and high sensitive cTnT 24 hours after CABG. Timepoint: 24 hours before and 8 and 24 hours after CABG. Method of measurement: CKMB and high sensitive cTnT (ELIZA).
- Secondary Outcome Measures
Name Time Method